Gastrointestinal Cancer News

Dafna Bar-Sagi , PhD, vice dean for science and chief scientific officer at NYU Langone Medical Center and senior member of its Perlmutter Cancer Center, received an Outstanding Investigator Award from the NCI.

Anal squamous cell carcinoma incidence rates increased among men and women or among women alone in all countries studied except Asian countries and Spain, according to study results.

The TAPUR trial, the first clinical trial launched by ASCO, is underway at 38 centers in five states.

BOSTON — Patients with hepatitis C infection cirrhosis treated with oral direct-acting antiviral agents were not at increased risk for developing hepatocellular carcinoma, according to study findings presented here.

The Association of Community Cancer Centers presented Michael O’Connell, MD, with its 2016 Clinical Research Award.

Cancers associated with tobacco use make up 40% of all United States cancer diagnoses, and tobacco use remains the leading preventable cause of cancer and cancer deaths in the United States, according to a recent CDC Vital Signs report.

The incidence of colorectal cancer may be increased in older men with elevated thyroid-stimulating hormone levels, study data show.

The phase 3 ONO-4538-12 trial designed to evaluate nivolumab in patients with unresectable advanced or recurrent gastric cancer refractory to, or intolerant of, standard therapy, met its primary endpoint of OS, according to the drug’s manufacturer.

The launch of the Watson for Genomics sequencing service has the potential to bring precision medicine to cancer treatment centers worldwide, according to a press release issued by IBM Watson Health and Quest Diagnostics.

Patients with advanced cancer should receive dedicated, early palliative care concurrently with standard oncology treatment, according to ASCO’s updated guidelines published in Journal of Clinical Oncology.